Clinical Evaluation of Cordio App in Adult ADHF Patients

Cordio Medical89 enrolled

Overview

Observational study on ADHF patients at one site in Israel. After signing informed consent and undergoing screening assessments, eligible patients will record sentences into a smartphone. The app will upload the vocal data to the sponsor's servers for analysis. The patient will record at hospital: admittion, release. Before hospital release, if applicable and upon patient agrreement, an app will be installed in a smartphone in order to continue the recording at home.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Congestive Heart Failure

Interventions

Cordio AppDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of ADHF (pulmonary congestion) * Known diagnosis of HF, with either preserved or reduced LVEF. * 18+ years old. * Able to understand and provide written informed consent. Exclusion Criteria: * Subjects unable to comply with the daily use of the application due to mental disorders. * GFR \<25 ml/min who are non-responsive to diuretic therapy or who are on chronic renal dialysis. * Subjects with congenital heart disease or mechanical right heart valve(s). * Airway and lung infection and Sepsis * Patients with severe alcohol or drug use. * Women who are pregnant or lactating.

Locations (1)

Rambam Health Care Facility

Haifa, Israel

Outcomes

Primary Outcomes

voice recording analysis - system is being developed to distinguish between 'dry' and 'wet' clinical state in ADHF patients (Speech Measure- SM- parameter)

Anyalysis of voice recordings; admission vs. discharge

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.